98%
921
2 minutes
20
Differential diagnosis between Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) using cerebrospinal fluid (CSF) biomarkers is challenging. A recent study suggested that the addition of Aβ38 and Aβ43 to a standard AD biomarker panel (Aβ40, Aβ42, t-tau, p-tau) to improve the differential diagnosis. We tested this hypothesis in an independent German cohort of CAA and AD patients and controls using the same analytical techniques. We found excellent discrimination between AD and controls and between CAA and controls, but not between AD and CAA. Adding Aβ38 and Aβ43 to the panel did not improve the discrimination between AD and CAA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963288 | PMC |
http://dx.doi.org/10.1002/acn3.51987 | DOI Listing |
Phys Chem Chem Phys
April 2019
Department of Physics and Engineering Physics, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E2, Canada.
We have performed first-principles calculations to investigate the possibility of shape memory loss in a member of the binary smart alloy family - NiTi. A detailed analysis of the transition kinetics and dynamical pathway reveals the possibility of the B19' phase of NiTi losing its shape memory when subjected to high stress conditions and is heated above a critical temperature, Tc. The B19' phase is predicted to transform to P1[combining macron]-NiTi, which is also predicted to be dynamically stable and temperature-quench recoverable.
View Article and Find Full Text PDF